Details for Patent: 11,744,802
✉ Email this page to a colleague
Which drugs does patent 11,744,802 protect, and when does it expire?
Patent 11,744,802 protects BIKTARVY and is included in one NDA.
This patent has forty patent family members in twenty-nine countries.
Drugs Protected by US Patent 11,744,802
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gilead Sciences Inc | BIKTARVY | bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate | TABLET;ORAL | 210251-001 | Feb 7, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,744,802
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 106645 | ⤷ Sign Up | |||
| Australia | 2016354007 | ⤷ Sign Up | |||
| Australia | 2020200995 | ⤷ Sign Up | |||
| Brazil | 102016026127 | ⤷ Sign Up | |||
| Canada | 2948021 | ⤷ Sign Up | |||
| Chile | 2018001199 | ⤷ Sign Up | |||
| China | 108348473 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
